Tirzepatide use is associated with a lower risk for CPAP use, hospitalization, and mortality in adults with obesity, T2D, and OSA.

Please provide your email address to receive an email when new articles are posted on . For changes in office blood pressure from baseline to 6 months, researchers found significant drops among those ...

Researchers found evidence for reduced risk of dying from all causes and cardiovascular disease when OSA patients were treated with CPAP versus non-CPAP users. Patients with obstructive sleep apnea ...

Thinking about using a CPAP machine to quell sleep apnea? It's not necessarily a good idea for everyone, a new evidence review argues. This common treatment for sleep apnea might increase some folks' ...

Please provide your email address to receive an email when new articles are posted on . An OSA-related heart rate response greater than 9.4 bpm or hypoxic burden greater than 87.1% minutes/hour ...

SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Resmed (RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today announced the publication of a ...